[go: up one dir, main page]

NO20080066L - Farmasoytiske preparater av mikronisert (4-klorfenyl) [4-(4-pyridylmetyl)ftalazin-1-yl] og salter derav, med umiddelbar frigivelse og hoyt legemiddelinnhold - Google Patents

Farmasoytiske preparater av mikronisert (4-klorfenyl) [4-(4-pyridylmetyl)ftalazin-1-yl] og salter derav, med umiddelbar frigivelse og hoyt legemiddelinnhold

Info

Publication number
NO20080066L
NO20080066L NO20080066A NO20080066A NO20080066L NO 20080066 L NO20080066 L NO 20080066L NO 20080066 A NO20080066 A NO 20080066A NO 20080066 A NO20080066 A NO 20080066A NO 20080066 L NO20080066 L NO 20080066L
Authority
NO
Norway
Prior art keywords
phthalazin
pyridylmethyl
micronized
chlorophenyl
immediate release
Prior art date
Application number
NO20080066A
Other languages
English (en)
Inventor
Thomas Backensfeld
Torsten Wagner
Adrian Funke
Kai Juergens
Kai Thode
Heiko Kranz
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of NO20080066L publication Critical patent/NO20080066L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Oppfinnelsen vedrører faste farmasøytiske formuleringer med umiddelbar frigivelse og høyt innhold av legemiddel, som omfatter mikronisert (4-klorfenyl)[4-(4-pyridylmetyl)ftalazin-1-yl] samt farmasøytisk akseptabele salter derav.
NO20080066A 2005-06-07 2008-01-04 Farmasoytiske preparater av mikronisert (4-klorfenyl) [4-(4-pyridylmetyl)ftalazin-1-yl] og salter derav, med umiddelbar frigivelse og hoyt legemiddelinnhold NO20080066L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05090167A EP1731154A1 (en) 2005-06-07 2005-06-07 Immediate-release and high-drug-load pharmaceutical formulations of micronised (4-chlorophenyl)|4-(4-pyridylmethyl)pht halazin-1-yl| and salts thereof
PCT/EP2006/005601 WO2006131394A1 (en) 2005-06-07 2006-06-06 Immediate-release and high-drug-load pharmaceutical formulations of micronised (4-chlorophenyl)[4-(4-pyridylmethyl)phthalazin-1-yl] and salts thereof

Publications (1)

Publication Number Publication Date
NO20080066L true NO20080066L (no) 2008-03-06

Family

ID=34938468

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080066A NO20080066L (no) 2005-06-07 2008-01-04 Farmasoytiske preparater av mikronisert (4-klorfenyl) [4-(4-pyridylmetyl)ftalazin-1-yl] og salter derav, med umiddelbar frigivelse og hoyt legemiddelinnhold

Country Status (22)

Country Link
EP (2) EP1731154A1 (no)
JP (1) JP2008542421A (no)
KR (1) KR20080017443A (no)
CN (1) CN101242841A (no)
AR (1) AR054377A1 (no)
AU (1) AU2006256853A1 (no)
BR (1) BRPI0611818A2 (no)
CA (1) CA2610977A1 (no)
CR (1) CR9577A (no)
CU (1) CU20070272A7 (no)
DO (1) DOP2006000128A (no)
EC (1) ECSP078037A (no)
GT (1) GT200600243A (no)
IL (1) IL187906A0 (no)
MX (1) MX2007015495A (no)
NO (1) NO20080066L (no)
PE (1) PE20070012A1 (no)
RU (1) RU2007147953A (no)
TW (1) TW200716114A (no)
UY (1) UY29585A1 (no)
WO (1) WO2006131394A1 (no)
ZA (1) ZA200800113B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1958616A1 (en) * 2007-02-13 2008-08-20 Bayer Schering Pharma Aktiengesellschaft Pharmaceutical formulations of 1-[4-chloroanilino]-4-[4-pyridylmethyl] phthalazine or salts thereof
EP1958615A1 (en) * 2007-02-13 2008-08-20 Bayer Schering Pharma Aktiengesellschaft Solid pharmaceutical formulations of a homogeneous dispersion of active principles having pH-dependent solubility
TW201618783A (zh) 2014-08-07 2016-06-01 艾森塔製藥公司 以布魯頓(Bruton)氏酪胺酸激酶(BTK)佔據和BTK再合成速率為基礎之治療癌症、免疫和自體免疫疾病及發炎性疾病之方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO4950519A1 (es) * 1997-02-13 2000-09-01 Novartis Ag Ftalazinas, preparaciones farmaceuticas que las comprenden y proceso para su preparacion
WO1999058126A1 (en) 1998-05-11 1999-11-18 The Endowment For Research In Human Biology, Inc. Use of neomycin for treating angiogenesis-related diseases

Also Published As

Publication number Publication date
MX2007015495A (es) 2008-02-22
CA2610977A1 (en) 2006-12-14
UY29585A1 (es) 2007-01-31
CR9577A (es) 2008-03-06
CN101242841A (zh) 2008-08-13
EP1731154A1 (en) 2006-12-13
GT200600243A (es) 2007-07-16
IL187906A0 (en) 2008-03-20
AR054377A1 (es) 2007-06-20
DOP2006000128A (es) 2006-12-15
AU2006256853A1 (en) 2006-12-14
KR20080017443A (ko) 2008-02-26
BRPI0611818A2 (pt) 2010-09-28
EP1888073A1 (en) 2008-02-20
JP2008542421A (ja) 2008-11-27
CU20070272A7 (es) 2010-09-30
WO2006131394A1 (en) 2006-12-14
RU2007147953A (ru) 2009-07-20
PE20070012A1 (es) 2007-02-07
ZA200800113B (en) 2009-07-29
ECSP078037A (es) 2008-01-23
TW200716114A (en) 2007-05-01

Similar Documents

Publication Publication Date Title
NO20080164L (no) N-(pyridin-2-yl)-sulfonamidderivater
DE602006014990D1 (de) Intranasale verabreichung von schnell wirkendem insulin
MX2010003923A (es) Formulacion farmaceutica de valsartan.
NO20080284L (no) Cannabionoid aktiv farmasoytisk ingrediens for forbedrede doseringsformer
UA94942C2 (ru) Фармацевтические композиции с ингибиторами dpp iv
NO20080827L (no) Faste doseringsformuleringer av narkotiske legemidler som har forbedret bukal adsorpsjon
NO20080220L (no) Formuleringer med hoy medikament belastning og doseringsformer
TW200744665A (en) Vitamin E succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
NO20074933L (no) Farmasoytisk sammensetning som innbefatter et indolylmaleimidderivat
WO2007149406A3 (en) Modified coagulation factor ix polypeptides and use thereof for treatment
NO20070785L (no) Sammensetninger for levering av svaert vannloselige medikamenter.
CA3030422C (en) Stabilizing excipients for therapeutic protein formulations
NO20074848L (no) Farmasoytiske former med forbedrede farmakokinetiske egenskaper
NO20084935L (no) Nikotinbaerende vaksineformulering
NO20085087L (no) Nye heterocykliske forbindelser
WO2008087367A3 (fr) Derives de (phenylthiazolyl)-phenyl-propan-1-one et de (phenyloxazodyl)-phenyl-propan-1-one substitues, preparations et utilisations
SG147450A1 (en) Sustained release pharmaceutical compositions comprising aplindore and derivatives thereof
NO20081942L (no) Karbamoylbenzotriazolderivater som inhibitorer av lipaser og fosfolipaser
EA201170512A1 (ru) Композиция для перорального введения
WO2005018605A3 (en) Novel formulation of ropinirole
WO2011037976A3 (en) Pramipexole pharmaceutical formulations
WO2007124700A3 (en) Pharmaceutical composition containing taxane derivative destined for the preparation of an infusion solution, method of preparation thereof and use thereof
NO20080066L (no) Farmasoytiske preparater av mikronisert (4-klorfenyl) [4-(4-pyridylmetyl)ftalazin-1-yl] og salter derav, med umiddelbar frigivelse og hoyt legemiddelinnhold
MY143549A (en) Compositions for external application, containing adenosyl cobalamin for improvement of skin diseases
WO2008013823A3 (en) Co-crystals of (2r-trans)-6-chloro-5-[[4-[(4-fluorophenyl)methyl]-2,5-dimethyl-1-piperazinyl]carbonyl]-n,n,1-trimethyl-alpha-oxo-1h-indole-3-acetamide

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application